Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

2013/09/N/NZ7/02143

Keywords:

schizophrenia risperidone mirtazapine escitaloprame

Descriptors:

  • NZ7_14: Pharmacy, pharmacotherapy, pharmacology

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Instytut Farmakologii PAN

woj. małopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

Katarzyna Kamińska 

Number of co-investigators in the project: 3

Call: PRELUDIUM 5 - announced on 2013-03-15

Amount awarded: 149 500 PLN

Project start date (Y-m-d): 2014-02-24

Project end date (Y-m-d): 2017-02-23

Project duration:: 36 months (the same as in the proposal)

Project status: Project settled

Information in the final report

  • Publication in academic press/journals (4)
  1. The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex
    Authors:
    Katarzyna Kamińska, Anna Górska, Karolina Noworyta-Sokołowska, Adam Wojtas, Zofia Rogóż, Krystyna Gołembiowska
    Academic press:
    Pharmacological Reports (rok: 2018, tom: 70(5), strony: 1023-1031), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2018.04.009 - link to the publication
  2. The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats.
    Authors:
    Kamińska K, Rogóż Z
    Academic press:
    Pharmacological Reports (rok: 2015, tom: 67(6), strony: 1183-1187), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2015.04.006. - link to the publication
  3. Corrigendum to "The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats" [Pharmacol. Rep. 67 (2015) 1183-1187].
    Authors:
    Kamińska K, Rogóż Z
    Academic press:
    Pharmacological Reports (rok: 2017, tom: S1734-1140(17), strony: 30057-9), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2017.01.019. - link to the publication
  4. Risperidone and escitalopram co-administration: A potential treatment of schizophrenia symptoms with less side effects.
    Authors:
    Kamińska K, Noworyta-Sokołowska K, Jurczak A, Górska A, Rogóż Z, Gołembiowska K
    Academic press:
    Pharmacological Reports (rok: 2017, tom: 69(1), strony: 13-21), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10. - link to the publication

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy